Early assessment of skeletal muscle damage after ischaemia-reperfusion injury using Tc-99m-glucarate

Vascular

Volumn 8, Issue 3, 2000, Pages 186-191

  Wiersema, A M ^a   Oyen, W J G ^a   Dirksen, R ^a   Verhofstad, A A J ^a   Corstens, F H M ^a   Van Der Vliet, J A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ischaemia reperfusion; mice model; skeletal muscle; specific early marker; Tc 99m glucarate

Indexed keywords

AMISCAN; GLUTARIC ACID; PYROPHOSPHATE TECHNETIUM TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY OCCLUSION; ARTICLE; CONTROLLED STUDY; HINDLIMB; HISTOPATHOLOGY; MOUSE; MUSCLE INJURY; MUSCLE NECROSIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SCINTIGRAPHY;

ANIMALS; GLUCARIC ACID; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NECROSIS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPERFUSION INJURY;

EID: 0034008979     PISSN: 17085381     EISSN: None     Source Type: Journal    
DOI: 10.1177/096721090000800303     Document Type: Article

References (17)

1. Oredsson S., Plate G., Qvarfordt P., Reperfusion injury in skeletal muscle. Transplantation Proceedings, 1995, 27, 2831–2833.
2. Mitrev Z., Beyersdorf F., Hallmann R., et al, Reperfusion injury in skeletal muscle: Controlled limb reperfusion reduces local and systemic complications after prolonged ischaemia. Cardiovascular Surgery, 1994, 2, 737–748.
3. Beyersdorf F., Matheis G., Krüger S., et al, Avoiding reperfusion injury after limb revascularization: Experimental observations and recommendations for clinical application. Journal of Vascular Surgery, 1989, 9, 757–766.
4. Feller A. M., Roth A. C., Russell R. C., Eagleton B., Suchy H., Debs N., Experimental evaluation of oxygen derived free radical scavengers in the prevention of reperfusion injury to skeletal muscle. Annals of Plastic Surgery, 1989, 22, 321–331.
5. Blebea J., Kerr J. C., Franco C. D., Padberg F. T. Jr., Hobson R. W. III, Technetium 99m pyrophosphate quantitation of skeletal muscle ischaemia and reperfusion injury. Journal of Vascular Surgery, 1988, 8, 117–124.
6. Orlandi C., Crane P. D., Edwards D. S., et al, Early scintigraphic detection of experimental myocardial infarction in dogs with technetium-99m-glucaric-acid. Journal of Nuclear Medicine, 1991, 32, 263–268.
7. Pak K. Y., Nedelman M. A., Kanke M., et al, An instant kit for labeling antimyosin fab’ with technetium-99-m: Evaluation in an experimental myocardial infarct model. Journal of Nuclear Medicine, 1992, 33, 144–149.
8. Ohtani H., Callahan R. J., Khaw B. A., Fishman A. J., Wilkinson R. A., Strauss H. W., Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats. Journal of Nuclear Medicine, 1992, 33, 1988–1993.
9. Yaoita H., Uehara U., Brownell A. L., et al, Localization of technetium-99m-glucarate in zones of acute cerebral injury. Journal of Nuclear Medicine, 1991, 32, 272–278.
10. Yaoita H., Fishman A. J., Wilkinson R., Khaw B. A., Juweid M., Strauss H. W., Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium. Journal of Nuclear Medicine, 1993, 34, 1303–1308.
11. Narula J., Petrov A., Pak K. Y., Khaw B. A., Tc-99m-glucarate in acute visualization of experimental nonreperfused myocardial infarction. Journal of Nuclear Medicine, 1994, 35, 4.
12. Schiable T., DeWoody K., Dann R., et al, Accurate diagnosis of acute deep venous thrombosis with technetium-99m antifibrin scintigraphy: Results of a phase III trial. Journal of Nuclear Medicine, 1991, 32, 1020.
13. Narula J., Petrov A., Pak K. Y., Lister B. C., Khaw B. A., Very early noninvasive detection of acute experimental nonreperfused myocardial infarction with 99m-Tc-labeled glucarate. Circulation, 1997, 95, 1577–1584.
14. Khaw B. A., Nakazawa A., O'Donnell S. M., Pak K. Y., Narula J., Avidity of technetium 99m glucarate for the necrotic myocardium: In vivo and in vitro assessment. Journal of Nuclear Cardiology, 1997, 4, 283–290.
15. Wiersema A. M., Dirksen R., Oyen W. J. G., van der Vliet J. A., A method for long duration anaesthesia for a new hindlimb ischaemia-reperfusion model in mice. Laboratory Animals, 1997, 31(2), 151–156.
16. Buja L. M., Tofe A. J., Kulkarni P. V., et al, Sites and mechanisms of localization of Tc-99m-phosphorous pharmaceuticals in acute myocardial infarcts and other tissues. Journal of Clinical Investigation, 1997, 60, 7245–7750.
17. Izquierdo C., Devous M. D., Nicod P., et al, A comparison of infarct identification with technetium-99m phyrophosphate and staining with triphenyl-tetrazolium chloride. Journal of Nuclear Medicine, 1983, 24, 492–497.